BEYFORTUS (nirsevimab) is the recently approved antibody injection which has been shown to lessen the severity of disease due to Respiratory Syncytial Virus (RSV).
It is available as a one time injection for infants up to 8 months of age, and will be given seasonally, starting on October 1st each year. Some children, ages 8 - 19 months who fall into certain risk groups may also be eligible to receive the antibody. More information about RSV disease and the new preventative treatments can be found here.
PHCA will be notifying eligible patients via MyChart message when we have the medication available. If you are not registered for MyChart please contact the office so we can get you signed up!